The authors would like to acknowledge ACEP staff members Megan Sambell, Prateek Sharma, Sam Shahid, and Yale University statistician and E-QUAL data analyst Craig Rothenberg for their support and contributions to this work.
Explore This Issue
ACEP Now: Vol 43 – No 12 – December 2024Dr. Zachrison is an associate professor of emergency medicine at Massachusetts General Hospital and Harvard Medical School and Chief of the Division of Health Services Research for Mass General Brigham Emergency Medicine.
Dr. Lo is the chief of emergency medicine at Sentara Norfolk General and professor at Eastern Virginia Medical School in Norfolk, Va. He is a partner with Emergency Physicians of Tidewater, a local private, democratic group, and chaired the ACEP clinical policy subcommittee on stroke thrombolytics.
Dr. Jauch is chair of the Department of Program Evaluation and Research at the University of North Carolina Health Sciences at MAHEC.
Dr. Venkatesh is professor and chair of emergency medicine at Yale School of Medicine and chief of emergency medicine at Yale New Haven Hospital.
References
- Radecki RP. Is the tPA-for-stroke debate over? ACEP Now. 2018;37(6).
- Power WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. [published correction appears in Stroke. 2019 Dec;50(12):e440-e441]. Stroke. 2019;50(12):e344-e418.
- ACEP. Thrombolytics for the management of acute ischemic stroke. Accessed November 4, 2024.
- Radecki RP. The latest research in neurologic emergencies. ACEP Now. 2024;43(9).
Pages: 1 2 3 | Single Page
No Responses to “Thrombolytics in Stroke: Moving Beyond Controversy to Comprehensive Care”